Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Manager’s Top Stock Picks for 2017
Mott Capital Management is a long-only fund managed by Michael Kramer.
Posts Tagged ‘Acadia Pharmaceuticals Inc (ACAD)’
Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects
March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks.
Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today
U.S. stock indexes are up substantially in Friday trading, with the S&P 500 hitting record highs, driven by a surprisingly strong jobs report out of the U.S.
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Why Are These Five Stocks In Spotlight Today?
U.S. equities inched up on Monday after fresh data displayed that consumer spending rose marginally in February.
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc.
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
Newfield Exploration Co. (NFX), ACADIA Pharmaceuticals Inc. (ACAD): How Did Andreas Halvorsen’s Small-Cap Picks Perform in Q3?
Andreas Halvorsen's Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking's flagship fund returned on average 19% per year.
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options.
Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)
In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP).
Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc.
Hedge Fund Resource Center
